A series of RNAi-related grants issued by the National Institutes of Health began this month, including one supporting research into the use of RNAi to treat kidney disease, one funding the development of new delivery vectors, and one that may help identify targets for cancer therapeutics.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.